News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Tejas Patil: Delighted to have contributed the ALK dataset to this AI study
Photo taken from Tejas Patil/X
Jul 12, 2024, 15:14

Tejas Patil: Delighted to have contributed the ALK dataset to this AI study

Tejas Patil, Thoracic oncologist CU Cancer Center, made the following post on X:

“Delighted to have contributed the ALK dataset to this AI study in Nature! DeepPT predicts tumor mRNA expression from H&E slides & ENLIGHT predicts response to targeted & immune therapies from the inferred expression values.”

Read further.Source: Tejas Patil/X

AI study ALK dataset cancer Cancer research CU Cancer Center DeepPT ENLIGHT H&E slides immune therapy prediction Nature publication OncoDaily Oncology oncology advancements targeted therapy prediction Tejas Patil thoracic oncologist tumor mRNA expression
Special Coverage
Blog
Nov 3, 2024, 14:02
Risk stratification/scoring in MPNs
Insight
Nov 3, 2024, 13:55
Highlights from JLCS24 by Stephen Liu
Blog
Nov 3, 2024, 13:43
Funding Success: March Biosciences Closes Oversubscribed $28.4 Million Series A Financing
Insight
Nov 3, 2024, 13:32
CANCaRe Africa: Working together to build a better future for children with cancer in Africa
Blog
Nov 3, 2024, 13:27
BCRF held its annual Symposium and Awards Luncheon to honor global group of 260+ breast cancer investigators
Blog
Nov 3, 2024, 13:06
Rana McKay: Honored to be among 12 outstanding oncology leaders on the ASCO Election ballot
Insight
Nov 3, 2024, 13:00
Christian Ntizimira: Reshaping palliative care globally
Insight
Nov 3, 2024, 12:51
Will the future of papillary renal cell carcinoma research offer tricks, or treats?
Blog
Nov 3, 2024, 12:50
Christine Lovly: Kicking off Lung Cancer Awareness Month with a message of hope from lung cancer survivor
Blog
Nov 3, 2024, 12:38
Beliz Bahar Karaoğlan: Is 3 months of adjuvant chemo enough for all low-risk stage III colon cancer patients?
Blog
Nov 3, 2024, 12:31
Yan Leyfman: Joanna Rhodes on how the immune system works to combat lymphomas
Insight
Nov 3, 2024, 12:29
Cast your vote in the ASCO Election! Help shape the future of oncology leadership